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Abstract
Purpose: Eosinophilic lung diseases are a group of pulmonary disorders associated with peripheral or tissue eosino-
philia. They can be classified into primary (idiopathic) and secondary groups based on their aetiology. On the other 
hand, blood eosinophilia is a common clinical problem with various causes. In many cases the lung infiltrations in 
patients with peripheral eosinophilia are non-eosinophilic. Herein, we aim to assess the relationship between blood 
eosinophilia and abnormal high-resolution computed tomography (HRCT) features and their extent in idiopathic 
chronic eosinophilic pneumonia (ICEP) (the most common form of idiopathic eosinophilic lung disease). This can 
help in differentiating eosinophilic from non-eosinophilic lung infiltrations in patients with blood eosinophilia.
Material and methods: In this descriptive-correlational study, all patients with proven ICEP, who were referred to Masih 
Daneshvari Hospital, Tehran, Iran from 2012 to 2019, were included. The ICEP diagnosis was based on lung infil-
trations on imaging, in addition to increased numbers of eosinophils in bronchoalveolar lavage fluid, blood or lung 
biopsy samples, and rapid response to corticosteroids. Patients with known aetiologies for eosinophilic lung diseases 
were excluded. The HRCT findings and their extent in each patient were compared with the blood eosinophil level.
Results: Positive correlation was found only between blood eosinophil level and frequency and extent of consolida-
tion, and with frequency of lymphadenopathy.
Conclusions: HRCT can help to differentiate eosinophilic from non-eosinophilic lung infiltrations in patients with 
blood eosinophilia by comparing the extent of consolidation with the blood eosinophil level.
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Introduction
Eosinophilic lung diseases are a group of pulmonary disor-
ders associated with peripheral or tissue eosinophilia [1].
This group of disorders can be classified into primary 
(idiopathic) and secondary groups based on their aetio-
logy. Secondary causes include infection, malignancy, 
allergies, and medications [2]. Primary eosinophilic lung 
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disease (idiopathic) can be classified as independent pul-
monary involvement versus systemic involvement. Two 
eosinophilic lung diseases with independent lung involve-
ment are acute eosinophilic pneumonia (AEP) and chronic 
eosinophilic pneumonia (CEP) [3].
Idiopathic chronic eosinophilic pneumonia (ICEP) 
is a rare form of diffuse lung parenchymal disease with 
an unknown cause, first described by Carington et al. in 
1969 [4]. It is, however, the most common of the idio-
pathic eosinophilic pulmonary disorders [5].
The diagnosis of ICEP is usually based on a combi-
nation of clinical manifestations, laboratory test results, 
bronchoalveolar lavage (BAL) results, radiological find-
ings, and sometimes biopsy findings. Clinical diagnosis is 
usually based on a triad of pulmonary symptoms lasting 
more than 2 weeks, abnormal findings on chest imaging, 
and excessive eosinophils in the serum or lung tissue [6]. 
Absence of infectious and parasitic diseases and relevant 
drug history as well as absence of systemic causes are im-
portant factors in the diagnosis of this disease [4, 6, 7].
The disease is characterized by progressive shortness 
of breath, cough, fever, weakness, and weight loss over 
a period of several weeks [4, 6, 7]. Less common manifes-
tations include rhinitis or sinusitis [8].
Increased serum IgE is seen in two-thirds of patients. 
ESR is usually elevated [9], and peripheral blood throm-
bocytosis has also been reported [10].
Eosinophilia in alveoli, especially at values above 40% 
(with an average of 58% in our series) in BAL, is a promi-
nent feature of ICEP. When CEP is suspected and serum 
eosinophilia is not significant, BAL may be helpful [11].
Histological findings also typically show the accu-
mulation of eosinophils and lymphocytes in alveoli and 
interstitial tissue and interstitial fibrosis [4, 12]. A biopsy 
for pathological confirmation is not usually required, but 
if performed, tissue findings may include interstitial and 
alveolar tissue inflammation with eosinophilic dominance 
as well as foci of organizing pneumonia [6].
Imaging findings, especially CT scans, can sometimes 
help to diagnose an eosinophilic lung disease. A common 
finding on chest radiography in CEP is nonsegmental 
peripheral airspace consolidation oedema, which mainly 
affects the upper lobes [4,13-15]. However, this finding 
is seen in less than 50% of cases [16]. In HRCT, opacities 
are almost bilateral and predominant in the upper lobes, 
and the most common findings are peripheral ground 
glass opacity and consolidation [17-19]. Nodular opaci-
ties, pleural effusion, pulmonary oedema, atelectasis, and 
pneumothorax may be seen [20].
Nevertheless, many lung infiltrations in patients with 
peripheral eosinophilia are non-eosinophilic, for example 
incidental blood eosinophilia of any aetiology concomi-
tant with primary infiltrating lung adenocarcinoma. In 
some cases, ICEP can be complicated by another pulmo-
nary disease, for instance superimposed pulmonary infec-
tions related to immunosuppression caused by cortico-
steroid therapy. In a number of these patients the classic 
HRCT features of CEP can be a differentiating clue, but 
in most cases the correct diagnosis is still difficult. Con-
sidering these challenges, in this article we aim to assess 
the relationship between HRCT findings and their extent 
with the blood eosinophilia level.
Material and methods
Patients and study design
This retrospective descriptive-correlational study was per-
formed at the Masih Daneshvari Hospital in Tehran, Iran 
from 2012 to 2019. During this period all patients with 
proven CEP, who were admitted to our hospital and had 
undergone lung HRCT prior to treatment, were included.
The CEP diagnosis was based on lung infiltrations on 
imaging plus increased number of eosinophils in bron-
choalveolar lavage fluid (BALF), blood, or lung biopsy 
samples, and rapid response to corticosteroids. Patients 
with history of known aetiologies for eosinophilic lung 
disease, such as drugs, parasitic infections, allergic bron-
chopulmonary aspergillosis, or acute presentation as well 
as clinical or pathological evidence of vasculitis or sys-
temic diseases were excluded from the study [21]. We also 
excluded cases with a history of prior corticosteroid treat-
ment or corticosteroid treatment in the interval between 
blood test and CT scan and patients with normal blood 
eosinophil levels.
The mean interval between blood eosinophil level test 
and lung HRCT was 3.23 ± 4 days.
Imaging technique
All patients underwent inspiratory HRCT from the lung 
apex to the lung base, with collimation of 1.5-2.0 mm at in-
tervals of 10-20 mm. Images were reviewed at lung (level, 
–700 to –550 H; width, 1200-1600 H) and mediastinal (level, 
20-50 H; width, 300-450 H) windows. None of the patients 
received an intravenous injection of contrast medium.
Analyses of high-resolution computed tomography 
findings
Each lung was divided into 3 separate lobes (RUL, RML, RLL 
for right lung and LUL, LLL, lingula for left lung). A check 
list of various findings of CEP on HRCT was designed.
For each HRCT feature, the presence, distribution, and 
extent were recorded. The extent of each abnormality was 
defined as the number of involved pulmonary lobes [22,23]. 
The number of abnormal lobes was defined as the number 
of pulmonary lobes affected by any of the HRCT findings.
Two thoracic radiologists blinded to the CEP diagno-
sis and laboratory results reviewed the HRCT images in-
dependently, according to the check list. The conclusions 
were reached through consensus.
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Statistical analyses
All data were analysed using SPSS version 22 software 
(IBM Corp. Released 2013. IBM SPSS Statistics for Win-
dows, Version 22.0, Armonk, NY: IBM Corp). P-values 
< 0.05 were considered statistically significant. Descrip-
tive data were presented as frequency, percentage, median, 
mean, and standard deviation.
To assess the relationship between blood eosinophil lev-
els and frequency as well as the extent of various abnormal 
HRCT findings, the Mann-Whitney U test and Spearman 
test were used, at a significance level of 0.05, respectively.
Ethical issues 
The research was approved by the National Research Insti-
tute of Tuberculosis and Lung Diseases (NRITLD) Ethics 
Committee (IR.SBMU.NRITLD.REC.1398.3), and written 
informed consent was obtained from each patient.
Results
In the current study, 52 cases with predetermined criteria 
were evaluated, of whom 33 were female and 19 were male. 
The participants’ mean age was 46.60 years with a standard 
deviation of 16.6.
The lowest density of eosinophils was 545/mm3 and 
the highest was 18760/mm3 (median of 1284/mm3 with 
a standard deviation of 5039.18). Sixteen patients had 
peri pheral blood eosinophils below 1000/mm3 (30.77%), 
and 36 patients had over 1000/mm3 (69.23 %).
The distribution of abnormal HRCT findings is dem-
onstrated in Table 1. The most prevalent abnormal lobes 
were LUL and RUL.  In our results, ground glass opac-
ity (Figure 1), reticulation, atelectasis, and consolidation 
(Figure 2) were the most frequent and extensive HRCT 
findings (Table 2). 
The mean and median numbers of abnormal lobes in 
our patients were 3.9 and 4, respectively, with a standard 
deviation of 1.54.
A statistically significant relationship was found be-
tween the blood eosinophil level and frequency and extent 
Table 1. Distribution of abnormal high-resolution computed tomography 










Figure 1. High-resolution computed tomography of lung in a 78-year-old female with blood eosinophil level of 1020/mm3. Note small and scattered patches 
of ground glass opacity in right and left upper lobes (A, B)
A B
Figure 2. High-resolution computed tomography of lung in a 30-year-old female with blood eosinophil level of 14 270/mm3. Note extensive and confluent 
patches of consolidation in right and left lungs (A, B)
A B
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Table 2. Frequency and extent of abnormal high-resolution computed tomography findings in chronic eosinophilic pneumonia patients
HRCT feature Frequency Percent Mean number  
of abnormal lobes 




Ground glass opacity 40 76.9 2.67 3 1.92
Reticulation 32 61.5 1.75 1 1.94
Atelectasis 29 55.8 0.94 1 0.98
Consolidation 18 34.6 0.65 0 1.17
Bronchiectasis 17 32.7 0.5 0 0.8
Lymphadenopathy 16 30.8 – – –
Pleural effusion 10 19.2 – – –
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Figure 3. A) Correlation between eosinophil levels and number of abnormal pulmonary lobes in computed tomography (CT) scan. B) Correlation between 
eosinophil levels and GGO extent in CT scan. C) Correlation between eosinophil levels and consolidation extent in CT scan 
R2 quadratic = 0.058 
R2 linear = 0.057
R2 quadratic = 0.167 
R2 linear = 0.156
R2 quadratic = 0.019 
R2 linear = 0.001A
C
B
of consolidation as well as the frequency of LAP (p-value: 
0.018, 0.021, and 0.023, respectively). Our results dem-
onstrated no statistically significant correlation between 
eosinophil level and other abnormalities. The correlation 
of eosinophil level and extent of consolidation, GGO, and 
abnormal pulmonary lobes is shown in Figure 3.
Discussion
In this study, we assessed the frequency, extent, and dis-
tribution of abnormal HRCT findings in ICEP and the 
relationship between these findings and peripheral blood 
eosinophil count.
According to our study, the disease has a 1.73 : 1 female 
predominance. The mean age of patients was 46.6 years, 
and HRCT findings have upper lobe predilection. All our 
findings were similar to previous studies [1,3,24,25]. 
In a review article by Matthew et al. it is stated that 
consolidation and GGO are the most common HRCT 
findings and are predominantly present in upper lobes [3]. 
In the current study, the most common abnormalities in 
HRCT were GGO, reticulation, atelectasis, and consolida-
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tion. Less common findings include bronchiectasis, LAP, 
pleural effusion, and nodule. These results are also similar 
to previous research [1,21,24-26]. In our study, GGO was 
the most frequent and extensive abnormality. However, in 
some similar studies consolidation was the most frequent 
finding [1]. This at least in part can be related to different 
slice thickness of HRCT and spiral CT images. 
We could not find any study that evaluated the relation-
ship between peripheral eosinophil level and HRCT find-
ings in the available literature. In a study by Poznanovic 
et al. a significant positive correlation between peripheral 
eosinophil level and paranasal mucosal disease based on 
CT was found [27].
In our research, among various abnormal HRCT find-
ings that were evaluated, only the frequency and extent of 
consolidation had a significant positive correlation with the 
level of peripheral eosinophilia. This means that in patients 
with ICEP, as the number of lobes with consolidation in-
creases, the level of blood eosinophilia also increases, and 
vice versa. We could not determine definite significant cut-
off values that could have practical clinical implication for 
differentiating between eosinophilic and non-eosinophilic 
lung infiltration (possibly because of the small number of 
patients).
Finally, our study had some limitations. It was retro-
spective, the sample volume was rather small, and the 
bronchoalveolar lavage fluid (BAL) eosinophil level was 
not included in the study. This might have some relation-
ship with HRCT findings. Also, it was limited to ICEP 
patients with peripheral eosinophilia.
Future prospective studies with larger numbers of pa-
tients and including various types of idiopathic and sec-
ondary eosinophilic lung infiltrations with blood eosino-
philia are required to verify our results and characterize 
any relationship between blood eosinophilia and HRCT 
findings in more detail.
Conclusions
Assessing the correlation between the extent of consoli-
dation on chest HRCT and blood eosinophil level may 
be helpful in differentiating eosinophilic from non-eosino-
philic lung infiltrations in patients with peripheral eosino-
philia.
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